NGNE ETF Ownership and Portfolio Weights

FILED AND SPONSOR-REPORTED ETF HOLDINGS

NGNE Included in ETFs

Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.

Current ETFs holding NGNE

3 latest ETF portfolios currently report this security.

ETF	Fund	Weight	Added / first observed	Latest report
BBC	Virtus Biotech Clinical Trials Etf	0.92195%	2026-01-30 (baseline)	2026-04-30
HELX	Franklin Genomic Advancements ETF	0.172958%	2025-12-31 (baseline)	2026-03-31
IWV	iShares Russell 3000 ETF	0.000525%	2025-12-31 (baseline)	2026-03-31

Previous ETFs holding NGNE

No previous ETF membership has been observed within the retained snapshot history.